One of the criteria I would look for in purchasing a pink sheet stock is a CEO who has a willingness and desire to garnish public attention and advocate for his field. Something Calkin is doing well. With that being said, I also think there needs to be a transition time for Robert to bring GRCU to the forefront and not allow it to stand behind CCI.
With all of the mention of Calkin in the news, there has yet to be an awareness built with the public at large that he is the CEO of Green Cures and Botanical Distribution. I've seen a brief plug where he mentions it in a news spot, and hopefully their marketing plan calls for a greater emphasis on highlighting the public entity, not just the private company.